• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微环境与多发性骨髓瘤的扩散

Microenvironment and multiple myeloma spread.

作者信息

Ribatti Domenico, Moschetta Michele, Vacca Angelo

机构信息

Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy, National Cancer Institute "Giovanni Paolo II", Bari, Italy.

Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy.

出版信息

Thromb Res. 2014 May;133 Suppl 2:S102-6. doi: 10.1016/S0049-3848(14)50017-5.

DOI:10.1016/S0049-3848(14)50017-5
PMID:24862128
Abstract

In patients with multiple myeloma (MM), the bone marrow (BM) contains hematopoietic stem cells (HSCs) and non-hematopoietic cells. HSCs are able to give rise to all types of mature blood cells, while the non hematopoietic component includes mesenchymal stem cells (MSCs), fibroblasts, osteoblasts, osteoclasts, chondroclasts, endothelial cells, endothelial progenitor cells (EPCs), B and T lymphocytes, NK cells, erythrocytes, megakaryocytes, platelets, macrophages and mast cells. All of these cells form specialized "niches" in the BM microenvironment which are close to the vasculature ("vascular niche") or to the endosteum ("osteoblast niche"). The "vascular niche" is rich in blood vessels where endothelial cells and mural cells (pericytes and smooth muscle cells) create a microenvironment that affects the behavior of several stem and progenitor cells. The vessel wall serves as an independent niche for the recruitment of endothelial progenitor cells, MSCs and HSCs. The activation by angiogenic factors and inflammatory cytokines switch the "vascular niche" to promote MM tumor growth and spread. This review will focus on the mechanisms involved in the generation of signals released by endothelial cells in the "vascular niche" that promote tumor growth and spread in MM.

摘要

在多发性骨髓瘤(MM)患者中,骨髓(BM)包含造血干细胞(HSCs)和非造血细胞。造血干细胞能够产生所有类型的成熟血细胞,而非造血成分包括间充质干细胞(MSCs)、成纤维细胞、成骨细胞、破骨细胞、软骨破骨细胞、内皮细胞、内皮祖细胞(EPCs)、B和T淋巴细胞、自然杀伤细胞(NK细胞)、红细胞、巨核细胞、血小板、巨噬细胞和肥大细胞。所有这些细胞在骨髓微环境中形成特殊的“龛位”,这些龛位靠近脉管系统(“血管龛位”)或骨内膜(“成骨细胞龛位”)。“血管龛位”富含血管,内皮细胞和壁细胞(周细胞和平滑肌细胞)在其中创造了一个影响多种干细胞和祖细胞行为的微环境。血管壁作为募集内皮祖细胞、间充质干细胞和造血干细胞的独立龛位。血管生成因子和炎性细胞因子的激活会使“血管龛位”转变,从而促进MM肿瘤的生长和扩散。本综述将聚焦于“血管龛位”中内皮细胞释放的促进MM肿瘤生长和扩散的信号产生机制。

相似文献

1
Microenvironment and multiple myeloma spread.微环境与多发性骨髓瘤的扩散
Thromb Res. 2014 May;133 Suppl 2:S102-6. doi: 10.1016/S0049-3848(14)50017-5.
2
Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.多发性骨髓瘤作为骨髓微环境在血管生成调控中作用的模型。
Int Rev Cell Mol Biol. 2015;314:259-82. doi: 10.1016/bs.ircmb.2014.10.004. Epub 2014 Nov 18.
3
Bone marrow vascular niche and the control of angiogenesis in multiple myeloma.骨髓血管龛与多发性骨髓瘤中血管生成的调控。
Front Biosci (Landmark Ed). 2014 Jan 1;19(2):304-11. doi: 10.2741/4209.
4
Bone Niches, Hematopoietic Stem Cells, and Vessel Formation.骨龛、造血干细胞与血管形成
Int J Mol Sci. 2017 Jan 13;18(1):151. doi: 10.3390/ijms18010151.
5
Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells.多发性骨髓瘤中的血管生成和血管发生:炎症细胞的作用
Recent Results Cancer Res. 2011;183:87-95. doi: 10.1007/978-3-540-85772-3_4.
6
The vascular niche: home for normal and malignant hematopoietic stem cells.血管壁龛:正常和恶性造血干细胞的家园。
Leukemia. 2012 Jan;26(1):54-62. doi: 10.1038/leu.2011.236. Epub 2011 Sep 2.
7
Do microRNAs regulate bone marrow stem cell niche physiology?微小 RNA 是否调节骨髓干细胞龛生理学?
Gene. 2012 Apr 10;497(1):1-9. doi: 10.1016/j.gene.2012.01.045. Epub 2012 Jan 28.
8
Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma.多发性骨髓瘤患者造血干细胞和祖细胞的内皮分化
Clin Cancer Res. 2008 Mar 15;14(6):1678-85. doi: 10.1158/1078-0432.CCR-07-4071.
9
The Hematopoietic Niche in Myeloproliferative Neoplasms.骨髓增殖性肿瘤中的造血微环境。
Mediators Inflamm. 2015;2015:347270. doi: 10.1155/2015/347270. Epub 2015 Nov 30.
10
Bone, microenvironment and hematopoiesis.骨、微环境与造血
Curr Opin Hematol. 2012 Jul;19(4):250-5. doi: 10.1097/MOH.0b013e328353c714.

引用本文的文献

1
Identification of biomarkers in multiple myeloma: A comprehensive study combining microarray analysis and Mendelian randomization.多发性骨髓瘤的生物标志物鉴定:结合微阵列分析和孟德尔随机化的综合研究。
J Cell Mol Med. 2024 Jun;28(12):e18504. doi: 10.1111/jcmm.18504.
2
Advances in nano-immunotherapy for hematological malignancies.血液系统恶性肿瘤的纳米免疫治疗进展
Exp Hematol Oncol. 2024 May 25;13(1):57. doi: 10.1186/s40164-024-00525-3.
3
Different evasion strategies in multiple myeloma.多发性骨髓瘤中的不同逃避策略。
Front Immunol. 2024 Feb 23;15:1346211. doi: 10.3389/fimmu.2024.1346211. eCollection 2024.
4
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications.多发性骨髓瘤中的肿瘤相关巨噬细胞:在疾病生物学中的关键作用及潜在的治疗意义。
Curr Oncol. 2023 Jun 25;30(7):6111-6133. doi: 10.3390/curroncol30070455.
5
In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy.利用脂质-聚合物纳米粒进行体内骨髓微环境 siRNA 递送来治疗多发性骨髓瘤。
Proc Natl Acad Sci U S A. 2023 Jun 20;120(25):e2215711120. doi: 10.1073/pnas.2215711120. Epub 2023 Jun 13.
6
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance.多发性骨髓瘤中血管生成和炎性细胞因子的信号通路:在浆细胞克隆性增殖和耐药中的作用
J Clin Med. 2022 Nov 1;11(21):6491. doi: 10.3390/jcm11216491.
7
The role of the bone microenvironment in regulating myeloma residual disease and treatment.骨微环境在调节骨髓瘤残留疾病及治疗中的作用。
Front Oncol. 2022 Aug 22;12:999939. doi: 10.3389/fonc.2022.999939. eCollection 2022.
8
Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation.Tenascin-C 促进膀胱癌的进展,其作用依赖于 syndecan-4,并涉及 NF-κB 信号通路的激活。
BMC Cancer. 2022 Mar 4;22(1):240. doi: 10.1186/s12885-022-09285-x.
9
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies.嵌合抗原受体 T 细胞免疫疗法:治疗血液系统 B 细胞恶性肿瘤的有力武器。
Front Med. 2021 Dec;15(6):783-804. doi: 10.1007/s11684-021-0904-z. Epub 2021 Dec 18.
10
The Emerging Role of Extracellular Vesicle-Associated RNAs in the Multiple Myeloma Microenvironment.细胞外囊泡相关RNA在多发性骨髓瘤微环境中的新作用
Front Oncol. 2021 Jun 21;11:689538. doi: 10.3389/fonc.2021.689538. eCollection 2021.